Centene Corporation (0HVB.L)
USD 59.65
(2.35%)
USD 59.65
(2.35%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 84.64 Billion USD | 7.77% |
| 2022 | 78.53 Billion USD | -1.53% |
| 2021 | 79.76 Billion USD | 14.2% |
| 2020 | 69.84 Billion USD | 70.37% |
| 2019 | 40.99 Billion USD | 32.66% |
| 2018 | 30.9 Billion USD | 41.39% |
| 2017 | 21.85 Billion USD | 8.21% |
| 2016 | 20.19 Billion USD | 175.2% |
| 2015 | 7.33 Billion USD | 26.01% |
| 2014 | 5.82 Billion USD | 65.03% |
| 2013 | 3.52 Billion USD | 27.22% |
| 2012 | 2.77 Billion USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 83.13 Billion USD | 0.62% |
| 2024 Q1 | 82.62 Billion USD | -3.81% |
| 2024 Q3 | 82.35 Billion USD | -0.95% |
| 2023 Q3 | 84.38 Billion USD | 1.84% |
| 2023 Q2 | 82.85 Billion USD | -0.16% |
| 2023 Q1 | 82.98 Billion USD | 5.66% |
| 2023 FY | 85.89 Billion USD | 9.37% |
| 2023 Q4 | 85.89 Billion USD | 1.8% |
| 2022 Q3 | 81.17 Billion USD | 0.14% |
| 2022 Q2 | 81.06 Billion USD | -2.22% |
| 2022 Q1 | 82.9 Billion USD | 3.94% |
| 2022 FY | 78.53 Billion USD | -1.53% |
| 2022 Q4 | 78.53 Billion USD | -3.24% |
| 2021 Q1 | 70.28 Billion USD | 2.28% |
| 2021 Q2 | 71.53 Billion USD | 1.78% |
| 2021 FY | 79.76 Billion USD | 14.2% |
| 2021 Q3 | 77.74 Billion USD | 8.67% |
| 2021 Q4 | 79.76 Billion USD | 2.59% |
| 2020 Q1 | 66.43 Billion USD | 62.05% |
| 2020 FY | 69.84 Billion USD | 70.37% |
| 2020 Q3 | 68.36 Billion USD | 0.02% |
| 2020 Q2 | 68.34 Billion USD | 2.88% |
| 2020 Q4 | 68.71 Billion USD | 0.52% |
| 2019 Q2 | 34.36 Billion USD | 2.38% |
| 2019 Q1 | 33.56 Billion USD | 8.63% |
| 2019 FY | 40.99 Billion USD | 32.66% |
| 2019 Q4 | 40.99 Billion USD | 19.68% |
| 2019 Q3 | 34.25 Billion USD | -0.34% |
| 2018 Q1 | 25.17 Billion USD | 15.17% |
| 2018 FY | 30.9 Billion USD | 41.39% |
| 2018 Q3 | 31.15 Billion USD | 8.4% |
| 2018 Q4 | 30.9 Billion USD | -0.82% |
| 2018 Q2 | 28.74 Billion USD | 14.2% |
| 2017 Q3 | 22 Billion USD | 0.73% |
| 2017 Q4 | 21.85 Billion USD | -0.66% |
| 2017 Q1 | 21.36 Billion USD | 5.77% |
| 2017 Q2 | 21.84 Billion USD | 2.24% |
| 2017 FY | 21.85 Billion USD | 8.21% |
| 2016 Q1 | 18.65 Billion USD | 154.15% |
| 2016 FY | 20.19 Billion USD | 175.2% |
| 2016 Q4 | 20.19 Billion USD | 2.87% |
| 2016 Q3 | 19.63 Billion USD | 0.71% |
| 2016 Q2 | 19.49 Billion USD | 4.52% |
| 2015 Q3 | 7.32 Billion USD | 4.27% |
| 2015 Q2 | 7.02 Billion USD | 4.87% |
| 2015 Q1 | 6.69 Billion USD | 14.97% |
| 2015 FY | 7.33 Billion USD | 26.01% |
| 2015 Q4 | 7.33 Billion USD | 0.23% |
| 2014 Q3 | 5.44 Billion USD | 16.31% |
| 2014 Q2 | 4.68 Billion USD | 5.31% |
| 2014 Q1 | 4.44 Billion USD | 26.0% |
| 2014 FY | 5.82 Billion USD | 65.03% |
| 2014 Q4 | 5.82 Billion USD | 6.93% |
| 2013 Q4 | 3.52 Billion USD | 12.42% |
| 2013 Q2 | 3.04 Billion USD | 5.48% |
| 2013 Q3 | 3.13 Billion USD | 3.08% |
| 2013 Q1 | 2.88 Billion USD | 4.08% |
| 2013 FY | 3.52 Billion USD | 27.22% |
| 2012 FY | 2.77 Billion USD | 0.0% |
| 2012 Q4 | 2.77 Billion USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Phreesia, Inc. | 371.08 Million USD | -22709.06% |
| Accuray Incorporated | 468.62 Million USD | -17961.486% |
| Align Technology, Inc. | 6.08 Billion USD | -1291.235% |
| Elevance Health Inc. | 108.92 Billion USD | 22.296% |
| AxoGen, Inc. | 196.82 Million USD | -42902.738% |
| Boston Scientific Corporation | 35.13 Billion USD | -140.895% |
| CVS Health Corporation | 249.72 Billion USD | 66.107% |
| Cardinal Health, Inc. | 45.12 Billion USD | -87.587% |
| DaVita Inc. | 17.61 Billion USD | -380.383% |
| HCA Healthcare, Inc. | 56.21 Billion USD | -50.577% |
| Hologic, Inc. | 9.15 Billion USD | -824.432% |
| Humana Inc. | 47.06 Billion USD | -79.839% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | -2496.409% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | -406.072% |
| Masimo Corporation | 3.04 Billion USD | -2682.87% |
| McKesson Corporation | 67.44 Billion USD | -25.5% |
| Patterson Companies, Inc. | 2.96 Billion USD | -2750.766% |
| Quest Diagnostics Incorporated | 14.02 Billion USD | -503.63% |
| ResMed Inc. | 6.87 Billion USD | -1131.609% |
| Henry Schein, Inc. | 10.57 Billion USD | -700.539% |
| Teladoc Health, Inc. | 4.39 Billion USD | -1827.001% |
| Universal Health Services, Inc. | 14.35 Billion USD | -489.551% |
| Veeva Systems Inc. | 5.91 Billion USD | -1331.943% |
| Baxter International Inc. | 28.27 Billion USD | -199.339% |
| Becton, Dickinson and Company | 52.78 Billion USD | -60.366% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | -448.14% |
| Danaher Corporation | 84.48 Billion USD | -0.181% |
| Stryker Corporation | 39.91 Billion USD | -112.069% |
| Medtronic plc | 89.98 Billion USD | 5.935% |